Multiplex Assays Market 2018-2025

2018-12-30 03:46:07


Multiplex Assays Market is Projected to Mask a Remarkable CAGR of 7.3% over the Forecast period.

Research Methodology:

Primary research: Interviews of various industry experts and supplement this with the best secondary sources for each study. The break-up of primary research is as follows:

By Company Type-  Tier 1: 40%, Tier 2: 32% & Tier 3: 28%

By Designation: C-Level Executives: 38%, Directors: 24% & Managers: 28%.

By Region- North America: 27%, Europe: 22%, Asia Pacific:30%, Rest of World:21%

Secondary research: Secondary sources and exclusive data and analytics with in-depth reporting.

Data Triangulation: After gaining insights from primary and secondary research, the research team analyzes data about the latest trends and key issues in reference to each country and industry and present it in report.

Market Segmentation:

By Offerings:



Software & Services

By Technology:

Flow Cytometry

Fluorescence Detection


Multiplex RT PCR

Other Technologies

By Type:

Protein Assays




Nucleic Acid Assays




Cell-based Assays

By Application:

Research & Development

Drug Discovery & Development

Biomarker Discovery and Validation

Clinical Diagnostics

Infectious Diseases


Cardiovascular Diseases

Autoimmune Disease

Nervous System Disorders

Metabolism & Endocrinology Disorders

Other Diseases

By End User:

Pharmaceutical & Biotechnology Companies

Hospitals & Academic Research Institutes

Reference Laboratories

Other End Users

Regional Segmentation:

North America (U.S. & Canada), Europe (Germany, UK, France, Italy, Spain, Russia, Poland, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Malaysia, Singapore, Australia, Rest of Asia-Pacific), Latin America (Brazil, Mexico, Rest of Latin America) and Middle East & Africa (GCC, South Africa, North Africa and Rest of Middle East & Africa)

Market Size & Forecast:

The market of multiplex assays is flourishing at a CAGR (Compound Annual Growth Rate) of 7.3% over the forecast period. The market is estimated to reach at an exponential value of USD 3.87 Billion at the end of 2025.

Regionally, North America region dominated the market of multiplex assays in 2017. Apart from this, Asia-Pacific region is projected to post the CAGR of 11.2% over the forecast period.

Market Drivers, Trends, Opportunities and Restraints:


Growing awareness about multifactorial nature of numerous diseases along with pathological conditions such as cancer and Alzheimer’s disease etc. created a requirement for instantaneous, cost-effective and time-saving measurement of multiple analyte in a single sample are believed to bolster the growth of multiplex assays market.  

Research Scope

- Overview of Main Industry Events and Analysis of Their Market Impact

- Executive Summary

- Market Drivers, Trends, Challenges and Opportunities

- Market Size and Forecast Projections

- Estimating Market Access in Each Region and Implications of the Emerging Technologies in the Market

- Macroeconomic Indicators of Various Countries Impacting the Growth of the Market

- Extensive Coverage of Industry Players including Recent Product Launches and Market Activities

- BCG Growth Share Matrix

- Porter’s Five Force Analysis


Reasons to Buy

The report will facilitate you to:

- Cultivate and design your in-licensing and out-licensing strategies through a review of marketed products and technologies.

- Develop business tactics by understanding the trends molding and thriving the market.

- Drive revenues by considering the vital trends, pioneering products and technologies, market segments and companies likely to impact the market in the future.

- Formulate effective sales and marketing strategies by examining the competitive landscape and by evaluating the performance of various competitors.

- Recognize emergent players with potentially strong product portfolios and develop effective counter-tactics to gain a competitive advantage.

- Unify your sales and marketing labors by recognizing the market segments that present utmost opportunities for consolidations, investments and strategic partnerships.

Market Players:

Luminex Corporation, Thermo Fisher Scientific, Inc., Illumina, Inc., Bio-Rad Laboratories, Inc., Qiagen N.V., Becton, Dickinson and Company, Abcam plc., Seegene Inc., Meso Scale Diagnostics, LLC., and Randox Laboratories Ltd. are some of the major players dominating the multiplex assays market globally.



Quick Buy Add to cart

Contact Us: